Bristol Myers Squibb Raises 2026 Revenue Forecast as Newer Drugs Drive Q3 Growth
The Bristol Myers Squibb Q3 2026 results lift revenue guidance as newer drugs grow 12%. EPS fell on a $1.6 billion charge.
Yutrepia Patent Ruling: Liquidia Plunges After Court Loss
Yutrepia patent ruling: a Delaware court found Liquidia's Yutrepia infringes two valid United Therapeutics patent claims, and Liquidia shares plunged.
Global Artificial Organs Market to Reach USD 63.31 Billion by 2035, Growing at 8.2% CAGR
FOR IMMEDIATE RELEASE — September 30, 2026 | Source: Acumen Research and Consulting Global Artificial Organs Market to Reach USD 63.31 Billion by 2035, Growing at 8.2% CAGR The global…
FDA Approves Rejoni’s Juveena Hydrogel System for Preventing Intrauterine Adhesions
The U.S. Food and Drug Administration has granted Premarket Approval to the Juveena Hydrogel System, a device developed by Rejoni, Inc. to reduce the formation and recurrence of intrauterine adhesions…
Siemens Healthineers Launches Accela Radiotherapy System
Siemens Healthineers unveiled the Accela radiotherapy system at ASTRO 2026, claiming multi-site SBRT in as little as 60 seconds. FDA 510(k) is pending.
FDA Approves Mirum’s Atebrioz for Ultra-Rare Fibrodysplasia Ossificans Progressiva
The U.S. Food and Drug Administration has approved Atebrioz (zilurgisertib), a once-daily oral therapy developed by Mirum Pharmaceuticals, for the treatment of fibrodysplasia ossificans progressiva in patients aged 12 years…
Anthropic Says Claude Helped Discover a Previously Unknown CRISPR-Like Enzyme System
Anthropic says Claude agents helped identify ART, a previously uncharacterized CRISPR-like repeat system in bacteriophages, after autonomously scanning 1.9 billion protein clusters, though the system's actual biological function remains unknown.
Anthropic and OpenEvidence Launch Free Medical AI for Doctors Across About 100 Countries
Anthropic and OpenEvidence are partnering to bring free, locally adapted clinical decision-support AI to doctors across roughly 100 low- and middle-income countries, building on pilot work in Rwanda and Botswana…
Pharming Reports Positive Phase II Results for Leniolisib in Rare Immune Disorders
Pharming has reported positive Phase II results for leniolisib in rare PI3Kδ-linked primary immunodeficiencies, showing a 26.4% mean spleen volume reduction in a 13-patient trial, with a larger CVID trial…
Karnataka FDA Hits 24 Drug Licences in Major Counterfeit-Medicine Crackdown
Karnataka's FDA has cancelled 16 drug licences and suspended eight more, including a Pfizer C&F depot, after uncovering a counterfeit-medicine racket that relabeled low-cost drugs as expensive life-saving injectables worth…
Intuitive Introduces Next-Generation da Vinci 5 Robotic Surgery System in India
Intuitive has launched its da Vinci 5 robotic surgery system in India, cleared for urologic, gynecologic, general, cardiac and thoracoscopic surgery, adding first-of-its-kind Force Feedback technology to a platform already…